Cronos Group Inc.

TSX:CRON.TO

Drug Manufacturers - Specialty & Generic

Healthcare
$4.57 -0.27%

-$0.01 today

Market cap
$1.67B
Beta
1.25
P/E (TTM)
-488.1
EPS (TTM)
-$0.01
52W Low $2.54High $4.66

Volume 0.15M

Average 0.19M

CRON.TO Net Debt

Total debt minus cash and equivalents; a negative value means the company holds more cash than debt.

Cronos Group Inc.TSX: CRON.TO

Net Debt · Q1 FY2026 · quarter ended Mar 2026

Net debt remains negative

Q1 FY2026 net debt was -$821.13M, compared with -$796M a year earlier.

Context

  • Net debt amounted to 70.0% of total assets at the end of Q1 FY2026, up 1.0 pp from a year earlier.
  • Net debt grew in size in 1 of the last 3 fiscal years.

What to watch

Whether net debt keeps falling in the next quarterly balance sheet after a -3.2% change from a year earlier.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterMar 2026
-$821.13M-4.2% QoQ
Last fiscal yearDec 2025
-$787.68M+8.1% YoY
Year agoMar 2025
-$796M-3.2% since
Net Debt past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-3.2%——
1 year+8.1%——
3-year CAGR———
5-year CAGR——
10-year CAGR——

Net Debt history

USD · from the balance sheet

Latest · FY2025
(787.68M) USD
Year-over-year change
+8.1%

Net Debt vs competitors

How CRON.TO compares with its peers on the latest reported figures

  • Peers report in different currencies, so net debt is compared through growth and share of total assets rather than absolute size.
  • Its year-over-year change of -3.2% is the 5th highest of 6, against a peer median of +34.3%.
  • Net debt amounts to 70.0% of total assets for CRON.TO, versus a peer median of 30.3%.
CRON.TO Competitors
Net Debt for CRON.TO and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
SIA.TOSienna Senior Living Inc.Sep 2026CA$1.21B CAD-1.8%+11.7%43.4%
WELL.TOWELL Health Technologies Corp.Mar 2026CA$656.99M CAD+77.0%+23.1%30.3%
EXE.TOExtendicare Inc.Jun 2026CA$552.28M CAD+161.1%—35.5%
TLRY.TOTilray Brands, Inc.Feb 2026$112.46M USD-21.9%-19.8%5.4%
GUD.TOKnight Therapeutics Inc.Mar 2026-CA$38.27M CAD+34.3%-37.6%3.5%
CRON.TOCronos Group Inc.Mar 2026-$821.13M USD-3.2%—70.0%
Peer median (excluding CRON.TO) —+34.3%-4.1%30.3%

Competitors are the stored peer set for CRON.TO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents886.97M764.64M669.29M858.81M790.35M
Short-term Investments116.7M113.08M192.24M039.93M
Net Receivables33.29M37.77M35.88M29.77M57.09M
Inventory32.8M37.56M30.5M33.15M46.66M
Other Current Assets07.11M5.41M14.39M8.33M
Total Current Assets1.08B960.16M933.31M936.11M942.37M
Property, Plant & Equipment (Net)82.95M62.83M60.82M134.58M147.02M
Goodwill1.1M1.03M1.06M63.45M66.36M
Intangible Assets18.08M26.7M21.08M11.13M8.87M
Long-term Investments135.16M89.75M54.74M2.81M28.46M
Tax Assets80.64M069.04M2.57M1.88M
Other Non-current Assets100K72.54M45K15.53M0
Total Non-current Assets318.02M252.85M206.78M230.07M252.59M
Total Assets1.4B1.21B1.14B1.17B1.19B
Account Payables11.11M11.16M12.13M16.97M11.62M
Short-term Debt2.69M000336.39K
Tax Payables3.49M37.09M11.76M11.84M0
Deferred Revenue26.07M0000
Other Current Liabilities7.32M15K102K40K(373.59K)
Total Current Liabilities53.92M68.12M41.4M49.7M48.1M
Long-term Debt00000
Deferred Tax Liabilities81K003.56M4.08M
Deferred Revenue (Non-current)00000
Other Non-current Liabilities1.91M1.38M1M1.07M733K
Total Non-current Liabilities9.09M3.93M2.56M5.63M5.98M
Total Liabilities63.46M72.05M43.96M55.33M54.08M
Common Stock595.5M611.32M662.17M669.88M661.78M
Retained Earnings659.42M490.68M416.72M457.71M446.94M
Accumulated OCI49.87M(797K)20.68M(63.53M)(16.81M)
Other Stockholders Equity00(48.45M)00
Minority Interest(2.97M)(2.92M)(3.45M)46.92M48.97M
Total Equity1.33B1.14B1.1B1.11B1.14B
Total Debt9.81M3.88M2.55M2.02M1.51M
Net Debt(877.17M)(760.77M)(666.74M)(856.79M)(787.68M)

Cronos Group Inc.

TSX:CRON.TO

Intrinsic Alpha fair value

Locked

Current Price

$4.57

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.